Walter Schuler
Novartis Institutes for BioMedical Research
Novartis Pharma AG
Basel
Switzerland
Name/email consistency: high
- Efficacy and safety of ABI793, a novel human anti-human CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation. Schuler, W., Bigaud, M., Brinkmann, V., Di Padova, F., Geisse, S., Gram, H., Hungerford, V., Kleuser, B., Kristofic, C., Menninger, K., Tees, R., Wieczorek, G., Wilt, C., Wioland, C., Zurini, M. Transplantation (2004)